X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/phanes-therapeutics-pt217-granted-fast-track-designation-by-the-fda-302110778.html
https://www.prnewswire.com/news-releases/phanes-therapeutics-pt886-granted-fast-track-designation-for-the-treatment-of-patients-with-metastatic-claudin-18-2-positive-pancreatic-adenocarcinoma-by-the-fda-302095196.html
https://www.prnewswire.com/news-releases/phanes-therapeutics-inc-announces-granting-of-registered-trademarks-for-its-three-proprietary-technology-platforms-by-the-us-patent-and-trademark-office-302047085.html
https://www.prnewswire.com/news-releases/phanes-therapeutics-inc-announces-clinical-trial-collaboration-and-supply-agreement-with-merck-to-evaluate-pt886-in-combination-with-keytruda-pembrolizumab-301955258.html
https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-the-appointment-of-internationally-renowned-oncologist-prof-shun-lu-to-its-clinical-advisory-board-301928437.html
https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-first-patient-dosed-in-phase-1-study-of-pt217-for-small-cell-lung-cancer-and-other-neuroendocrine-cancers-expressing-dll3-301920004.html
https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-the-establishment-of-oncology-clinical-advisory-board-301918189.html
https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-the-appointment-of-rita-laeufle-md-phd-as-chief-medical-officer-301837600.html
https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-first-patient-dosed-in-phase-1-study-of-pt886-for-advanced-gastric-gastroesophageal-junction-and-pancreatic-adenocarcinomas-301776427.html
https://www.prnewswire.com/news-releases/phanes-therapeutics-entered-into-a-research-collaboration-with-xyphos-biosciences-inc-an-astellas-company-301761304.html
Market Place
Share 
